Evommune Inc. (EVMN) vs Vanda Pharmaceuticals Inc. (VNDA)
Evommune Inc. and Vanda Pharmaceuticals Inc. are both Biotechnology companies. Evommune Inc. and Vanda Pharmaceuticals Inc. are of similar size ($309.9M and $301.1M). Evommune Inc. has the higher net margin (0.00% vs −127.4%) and the higher return on invested capital (−82.5% vs −217.6%). Across the 13 metrics below, Evommune Inc. leads on 9 and Vanda Pharmaceuticals Inc. on 4.
Valuation
Profitability
| Metric | EVMN | VNDA | Biotechnology median |
|---|---|---|---|
| Gross margin | — | 93.74% | 65.16% |
| Operating margin | 0.00% | (86.07%) | 0.00% |
| Net margin | 0.00% | (127.41%) | 0.00% |
| Free cash flow margin | 0.00% | (70.93%) | 0.00% |
| Return on equity | (141.99%) | (77.81%) | (57.72%) |
| Return on assets | (62.71%) | (53.00%) | (49.22%) |
| Return on invested capital | (82.46%) | (217.59%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack